+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Carotid and Renal Artery Stents Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

  • PDF Icon

    Report

  • 53 Pages
  • December 2023
  • Region: Global
  • GlobalData
  • ID: 5714518
The Medical Devices sector report, “Carotid and Renal Artery Stents Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update' provides comprehensive information about the Carotid and Renal Artery Stents pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Carotid artery stents are expandable tubes that are implanted in narrowed carotid arteries to increase the flow of blood. Carotid arteries become narrowed due to plaque formation and buildup in the inner surface of the arteries.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Carotid and Renal Artery Stents under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Carotid and Renal Artery Stents and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Carotid and Renal Artery Stents under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Carotid and Renal Artery Stents Overview
3 Products under Development
3.1 Carotid and Renal Artery Stents - Pipeline Products by Stage of Development
3.2 Carotid and Renal Artery Stents - Pipeline Products by Segment
3.3 Carotid and Renal Artery Stents - Pipeline Products by Territory
3.4 Carotid and Renal Artery Stents - Pipeline Products by Regulatory Path
3.5 Carotid and Renal Artery Stents - Pipeline Products by Estimated Approval Date
3.6 Carotid and Renal Artery Stents - Ongoing Clinical Trials
4 Carotid and Renal Artery Stents - Pipeline Products under Development by Companies
4.1 Carotid and Renal Artery Stents Companies - Pipeline Products by Stage of Development
4.2 Carotid and Renal Artery Stents - Pipeline Products by Stage of Development
5 Carotid and Renal Artery Stents Companies and Product Overview6 Carotid and Renal Artery Stents- Recent Developments
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
  • Carotid and Renal Artery Stents - Pipeline Products by Stage of Development
  • Carotid and Renal Artery Stents - Pipeline Products by Segment
  • Carotid and Renal Artery Stents - Pipeline Products by Territory
  • Carotid and Renal Artery Stents - Pipeline Products by Regulatory Path
  • Carotid and Renal Artery Stents - Pipeline Products by Estimated Approval Date
  • Carotid and Renal Artery Stents - Ongoing Clinical Trials
  • Carotid and Renal Artery Stents Companies - Pipeline Products by Stage of Development
  • Carotid and Renal Artery Stents - Pipeline Products by Stage of Development
  • Glossary
List of Figures
  • Carotid and Renal Artery Stents - Pipeline Products by Stage of Development
  • Carotid and Renal Artery Stents - Pipeline Products by Segment
  • Carotid and Renal Artery Stents - Pipeline Products by Territory
  • Carotid and Renal Artery Stents - Pipeline Products by Regulatory Path
  • Carotid and Renal Artery Stents - Pipeline Products by Estimated Approval Date
  • Carotid and Renal Artery Stents - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Acotec Scientific Holdings Ltd
  • Contego Medical LLC
  • CR Bard Inc
  • Evasc Medical Systems Corp
  • InspireMD Inc
  • MicroPort Scientific Corp
  • Nesstent Ltd.
  • Palmaz Scientific Inc (Inactive)
  • SurModics Inc